Social disparities explain differences in hypertension prevalence, detection and control in Colombia

Journal of Hypertension

Volumn 34, Issue 12, 2016, Pages 2344-2352

  Camacho, Paul A ^a,b   Gomez Arbelaez, Diego ^a,c   Molina, Dora I ^d   Sanchez, Gregorio ^e   Arcos, Edgar ^f   Narvaez, Claudia ^g   García, Henry ^h   Pérez, Maritza ⁱ   Hernandez, Erick A ^j   Duran, Myriam ^c   Cure, Carlos ^k   Sotomayor, Aristides ^l   Rico, Alvaro ^m   David, Tannia M ^c   Cohen, Daniel D ^a   Rangarajan, Sumathy ⁿ   Yusuf, Salim ⁿ   Lopez Jaramillo, Patricio ^a,c  

^a Desarrollo e Innovació n Tecnoló gica   (Colombia)

^b UNIVERSIDAD AUTÓNOMA DE BUCARAMANGA   (Colombia)

^c UNIVERSIDAD DE SANTANDER   (Colombia)

^d UNIVERSIDAD DE CALDAS   (Colombia)

^e UNIVERSIDAD DEL QUINDÍO   (Colombia)

^f Fundació n Cometa   (Colombia)

^g Hospital Susana Lopez de Valencia   (Colombia)

^h Fundació n RIESCAR   (Mexico)

ⁱ UNIVERSIDAD MILITAR NUEVA GRANADA   (Colombia)

^j Endocare Research Institute   (Colombia)

^k UNIVERSIDAD DEL NORTE   (Colombia)

^l Centro Cardiovascular Santa Lucia IPS   (Colombia)

^m FUNDEMOS   (Colombia)

ⁿ MCMASTER UNIVERSITY   (Canada)

more..

Author keywords

Awareness; Colombia; Control; Hypertension; Prevalence; Social disparities; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; COLOMBIA; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; FEMALE; HEALTH EDUCATION; HIGH INCOME COUNTRY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL GEOGRAPHY; MIDDLE INCOME COUNTRY; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SOCIAL ASPECT; SYSTOLIC BLOOD PRESSURE; URBAN AREA; AGE; ATTITUDE TO HEALTH; BODY MASS; COMBINATION DRUG THERAPY; EDUCATIONAL STATUS; HEALTH DISPARITY; INCOME; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR; RURAL POPULATION; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; URBAN POPULATION; WAIST HIP RATIO;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; COLOMBIA; DRUG THERAPY, COMBINATION; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS DISPARITIES; HUMANS; HYPERTENSION; INCOME; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; RURAL POPULATION; SEX FACTORS; URBAN POPULATION; WAIST-HIP RATIO;

EID: 84988596801     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000001115     Document Type: Article

References (48)

1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-2260.
2. Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, et al. National, regional, and global trends in systolic blood pressure since 1980: Systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011; 377: 568-577.
3. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics 2014 update: A report from the American Heart Association. Circulation 2014; 129: E28-e292.
4. Lozano R, Naghavi M, Foreman KT, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Diseases Study 2010. Lancet 2012; 380: 2095-2128.
5. World Health Organization. A global brief on hypertension: Silent killer, global public health crisis. Available at http: Apps.who.int/iris/bitstream/10665/79059/WHO-DCO-WHD-2013.2-eng.pdf [Accessed 23 July 2015].
6. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: E442.
7. Yusuf S, McKee M. Documenting the global burden of cardiovascular disease: A major achievement but still a work in progress. Circulation 2014; 129: 1459-1462.
8. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746-2753.
9. Pereira M, Lunet N, A. Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009; 27: 963-975.
10. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension. Lancet 2005; 365: 217-223.
11. Kayima J, Wanyenze RK, Katamba A, Leontsini E, Nuwaha F. Hypertension awareness, treatment and control in Africa: A systematic review. BMC Cardiovasc Disord 2013; 13: 54.
12. Yip W, Wong TY, Jonas JB, Zheng Y, Lamoureux EL, Nangia V, Sabanayagam C. Prevalence, awareness, and control of hypertension among Asian Indians living in urban Singapore and rural India. J Hypertens 2013; 31: 1539-1544.
13. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al., PURE (Prospective Urban Rural Epidemiology) Study Investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310: 959-968.
14. Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S, PURE Investigators- Writing Group. The Prospective Urban Rural Epidemiology (PURE) study: Examining the impact of societal influences on chronic noncommunicable diseases in low-, middle, and high-income countries. Am Heart J 2009; 158: 1-7.e1.
15. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al., INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364: 937-952.
16. Departamento Administrativo Nacional de Estadistica (DANE); Estadisticas por tema: Pobreza y Condiciones de Vida, 2016 [homepage en Internet]. Colombia: Departamento Administrativo Nacional Estadistica; 2016 [actualizada 12 febrero 2016; consultado 12 febrero 2016]. Available at: Http://www.dane.gov.co/index.php/estadisticas-portema/pobreza-y-condiciones-de-vida/.
17. Ministerio de Salud y Protección Social. Dirección de Epidemiología y Demografía. Grupo ASIS. Análisis de Situación de Salud según regiones Colombia [Monografía en Internet]. Colombia: Ministerio de Salud y Protección Social; 2012. Available at: Https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/PSP/ASIS%2024022014. pdf.
18. IPAQ. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-Short and Long Forms. IPAQ; 2005; https://sites.google.com/site/theipaq/[Accessed 23 June 2015].
19. Assad MA, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood pressure according to the International protocol: The Omron M5-I and the Omron 705IT. Blood Pres Monit 2003; 8: 127-133.
20. Omboni S, Riva I, Giglio A, Caldara G, Groppelli A, Parati G. Validation of the Omron M5-I, R5-I and HEM 907 automated blood pressure monitors in elderly individuals according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2007; 12: 233-242.
21. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-520.
22. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign, IL: Human Kinetic Books; 1988; 177.
23. Hosmer D, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons; 2000.
24. Gamboa L, Londoño E. Assessing educational unfair inequalities at a regional level in Colombia. Lecturas de Economía 2015; 83: 97-133.
25. Nissinen A, Böthig S, Granroth H, Lopez AD. Hypertension in developing countries. World Health Stat Q 1988; 41: 141-154.
26. Mendez MA, Cooper R, Wilks R, Luke A, Forrester T. Income, education, and blood pressure in adults in Jamaica, a middle-income developing country. Int J Epidemiol 2003; 32: 400-408.
27. Legido-Quigley H, Camacho Lopez PA, Balabanova D, Perel P, Lopez- Jaramillo P, Nieuwlaat R, et al. Patients' knowledge, attitudes, behaviour and healthcare experiences on the prevention, detection, management and control of hypertension in Colombia: A qualitative study. PLoS One 2015; 10: E0122112.
28. Li G, Wang H, Wang K, Wang W, Dong F, Qian Y, et al. Prevalence, awareness, treatment, control and risk factors related to hypertension among urban adults in Inner Mongolia 2014: Differences between Mongolian and Han populations. BMC Public Health 2016; 16: 294.
29. Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S, et al., Turkish Society of Hypertension and Renal Diseases. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens 2016; 34: 1208-1217.
30. Busingye D, Arabshahi S, Subasinghe AK, Evans RG, Riddell MA, Thrift AG. Do the socioeconomic and hypertension gradients in rural populations of low- And middle-income countries differ by geographical region? A systematic review and meta-analysis. Int J Epidemiol 2014; 43: 1563-1577.
31. de Gaudemaris R, Lang T, Chatellier G, Larabi L, Lauwers-Cances V, Maitre A, Diene E. Socioeconomic inequalities in hypertension prevalence and care: The IHPAF Study. Hypertension 2002; 39: 1119-1125.
32. Cha SH, Park HS, Cho HJ. Socioeconomic disparities in prevalence, treatment, and control of hypertension in middle-aged Koreans. J Epidemiol 2012; 22: 425-432.
33. Kaplan MS, Huguet N, Feeny DH, McFarland BH. Self-reported hypertension prevalence and income among older adults in Canada and the United States. Soc Sci Med 2010; 70: 844-849.
34. Marmot M. Social determinants of health inequalities. Lancet 2005; 365: 1099-1104.
35. Marmot M, Bell R. Fair society, healthy lives. Public Health 2012; 126 (suppl 1): S4-S10.
36. Galobardes B, Shaw M, Lawlor DA, Lynch JW, Davey Smith G. Indicators of socioeconomic position (part 1). J Epidemiol Community Health 2006; 60: 7-12.
37. Sanchez RA, Ayala M, Baglivo H, Velazquez C, Burlando G, Kohlmann O, et al., Latin America Expert Group. Latin American guidelines on hypertension. Latin American Expert Group. J Hypertens 2009; 27: 905-922.
38. Rodríguez J, Ruiz F, Peñaloza E, Eslava J, Gómez LC, Sánchez H, et al., Colombia, Ministerio de la Protección Social. Encuesta Nacional de Salud 2007: Resultados nacionales. Bogotá: JAVEGRAF; 2009.
39. López-Jaramillo P, Camacho PA, Forero-Naranjo L. The role of environment and epigenetics in hypertension. Expert Rev Cardiovasc Ther 2013; 11: 1455-1457.
40. Seclén S, Leey J, Villena A, Herrera B, Menacho J, Carrasco A, et al. Prevalencia de diabetes mellitus hipertensión arterial, hipercolesterolemia y obesidad como factores de riesgo coronario y cerebrovascular en población adulta de la costa sierra y selva del Perú . Acta Med Peru 1999; 17: 8-12.
41. López-Jaramillo P, Sánchez RA, Diaz M, Cobos L, Bryce A, Parra Carrillo JZ, et al., Latin America Expert Group. Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome. J Hypertens 2013; 31: 223-238.
42. Jatoi NA, Jerrard-Dunne P, Feely J, Mahmud A. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension. Hypertension 2007; 49: 981-985.
43. Benowitz NL, Sharp DS. Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers. Circulation 1989; 80: 1309-1312.
44. Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure. Hypertension 2001; 37: 187-193.
45. Corsi DJ, Subramanian SV, Chow CK, McKee M, Chifamba J, Dagenais G, et al. Prospective Urban Rural Epidemiology (PURE) study: Baseline characteristics of the household sample and comparative analyses with national data in 17 countries. Am Heart J 2013; 166: 636-646.e4.
46. Perel P, Bianco E, Poulter N, Prabhakaran D, Pais P, Ralston J, et al. Reducing premature cardiovascular mortality by 2025: The World Heart Federation Roadmap. Glob Heart 2015; 10: 97-98.
47. Lopez-Jaramillo P, Molina DI. The 20T20 Latin American Society of Hypertension target. J Hypertens 2015; 33: 189-190.
48. Patel P, Ordunez P, DiPette D, Escobar MC, Hassell T, Wyss F, et al., Standardized Hypertension Treatment and Prevention Network. Improved blood pressure control to reduce cardiovascular disease morbidity and mortality: The standardized hypertension treatment and prevention project. J Clin Hypertens (Greenwich) 2016; [Epub ahead of print].